Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through ...

Stanford University scientists have developed a brain implant designed to "hear" and vocalize words a person with severe ...

A multicenter French study led by Rennes University Hospital reports potential benefits of glucagon-like peptide-1 receptor ...

Novo Nordisk’s wildly popular GLP-1 drug Wegovy has been approved for use against a serious form of liver disease.

The capabilities of artificial intelligence are expanding every day. UC Davis is harnessing AI in many beneficial ways. Here, ...

Experts explain 'Ozempic vulva' as increasingly more women share their experience on this bizarre side effect.

What is 'food noise' and is it scuppering your weight loss goals? An expert spoke exclusively to GB News about the reasons behind your cravings ...

For those unfamiliar with The Biggest Loser, the American show challenged obese or overweight contestants to go head-to-head in a bid to lose the highest percentage of weight over a period of 30 weeks ...

Major U.S. equities indexes were little changed Monday morning, ahead of retail sector earnings reports and comments from ...

Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients ...

From depression to dementia, we are now realising the profound impacts of long-term inflammation on the brain. A better understanding of the underlying mechanisms is unlocking new treatments to protec ...

Jelly Roll opens up about the daring things he plans to do after hitting his weight loss goal—including some things that are ...